Fundraising FoxRayThera
3 known investors
Find your way into RayThera
Sign up to see every warm intro you have to RayThera
- Paths you didn't know you had: your email and LinkedIn already hold routes to the RayThera team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
A biopharmaceutical company developing therapies for neurology, immunology, and rare diseases. The page describes work focused on treating hard-to-treat conditions.
Investors · 3
Foresite Capitallisted by Foresite CapitalWest Hollywood
How we know: Foresite Capital's portfolio page · a partner's Signal profile · funding news · Not right? Tell us
OrbiMedlisted by OrbiMedNew York · $1M – $75M
How we know: OrbiMed's portfolio page · a partner's Signal profile · funding news · the VCSheet dataset · Not right? Tell us
TTMlisted by TTM
How we know: TTM's portfolio page · Not right? Tell us
Funding
SEC filings, press & company announcements$110M disclosed across 1 round · 2025
- $110MSeries AApr 2025 · 2 sourcesSource ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does RayThera do?
- A biopharmaceutical company developing therapies for neurology, immunology, and rare diseases. The page describes work focused on treating hard-to-treat conditions.
- Who are RayThera's investors?
- RayThera's investors include Foresite Capital, OrbiMed, TTM.
- How much funding has RayThera raised?
- RayThera has disclosed $110M raised across 1 round.